Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
“The low incidence of acute and chronic GVHD, in the absence of additional immunosuppression are distinct advantages in using the CliniMACS CD34 Reagent System,” said Dr. Robert J. Soiffer, Chief of the Division Hematologic Malignancies at the Dana-Farber Cancer Institute and investigator in the Blood and Marrow Transplant Clinical Trials Network.
With more than 1,300 employees in 22 countries, Miltenyi Biotec is a global therapy developer and provider of products and services that advance biomedical research and cell therapy. For the last 25 years, the company’s innovative tools have supported research at every level, from basic and translational research to clinical application. This complete portfolio of products and solutions enables scientists and clinicians to access, analyze, and utilize primary cells and primary-derived cells. Areas of clinical focus include hematology, graft engineering, immunotherapies, and apheresis.
Media Contact:
Marc Longpre
+1 415-318-4267
press@miltenyibiotec.de
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.